Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.3 USD | +2.52% | -0.56% | -16.96% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.96% | 1.3B | |
+14.77% | 118B | |
+13.03% | 106B | |
-3.03% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-17.13% | 15.56B | |
+4.54% | 13.63B | |
+28.25% | 12.27B |
- Stock Market
- Equities
- AKRO Stock
- News Akero Therapeutics, Inc.
- Morgan Stanley Adjusts Price Target on Akero Therapeutics to $40 From $30, Maintains Equalweight Rating